ArcBest (ARCB) Misses Q4 EPS by 11c

ArcBest (NASDAQ: ARCB) reported Q4 EPS of $2.45, $0.11 worse than the analyst estimate of $2.56. Revenue for the quarter came in at $1.24 billion versus the consensus estimate of $1.25 billion.

For earnings history and earnings-related data on ArcBest (ARCB) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Acurx Pharmaceuticals (ACXP) Tops Q2 EPS by 4c
• HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c